Efficacy of Therapeutic Plasma Exchange and Hemodialysis in the Treatment of Theophylline Intoxication
PDF
Cite
Share
Request
Letter to the Editor
VOLUME: 22 ISSUE: 1
P: 1 - 2
September 2026

Efficacy of Therapeutic Plasma Exchange and Hemodialysis in the Treatment of Theophylline Intoxication

Med J Bakirkoy 2026;22(1):1-2
1. University of Health Sciences Türkiye Bakırköy Dr. Sadi Konuk Training and Research Hospital, Clinic of Pediatric Intensive Care Unit, İstanbul, Türkiye
No information available.
No information available
Received Date: 04.11.2025
Accepted Date: 03.03.2026
Online Date: 25.09.2026
Publish Date: 25.09.2026
PDF
Cite
Share
Request

Dear Editor,

Theophylline is a methylxanthine derivative used to treat bronchospastic disorders in children and adults, and to address apnea and bradycardia in newborns (1, 2). As a methylxanthine derivative, theophylline increases intracellular cyclic adenosine monophosphate by inhibiting phosphodiesterase, thereby inducing smooth muscle relaxation. Blood theophylline levels above 15 μg/mL are associated with a risk of toxicity, whereas serum concentrations between 5-15 μg/mL are considered safe and effective (3). Because of its narrow therapeutic window, both chronic use and acute ingestion can cause serious poisoning. Management aims to reduce gastrointestinal absorption, monitor serum levels, and treat cardiac, neurological, and metabolic complications. Although extracorporeal elimination methods such as hemoperfusion, hemodialysis, and therapeutic plasma exchange (TPE) have been employed in intoxication cases, supportive care remains the cornerstone of treatment (4).

We report the case of a 15-year-old female who developed severe toxicity following the intentional ingestion of 30 tablets of sustained-release theophylline (Teokap® SR 200 mg) and who was admitted to our pediatric intensive care unit approximately 10 hours later. At the initial center, gastric lavage and activated charcoal were administered one hour after ingestion, but treatment was discontinued because the family refused further care. Eight hours later, the patient re-presented with palpitations and hand tremors, and was transferred to our hospital. On admission, she was conscious (Glasgow Coma Scale 15), with a blood pressure of 90/68 mmHg, a heart rate of 153 bpm, a respiratory rate of 19/min, and a temperature of 37 °C. Tremor, nystagmus, and hyperreflexia were observed, whereas examinations of other systems were unremarkable. The patient’s serum theophylline level was 49.4 μg/mL at admission.

Laboratory findings revealed leukocytosis (20,110/mm3), serum potassium of 3.2 mmol/L, lactate of 5.6 mmol/L, and metabolic alkalosis (pH 7.45, HCO3 21.7 mmol/L). The electrocardiography showed sinus tachycardia. Intravenous hydration was initiated with 0.9% NaCl, followed by maintenance fluids containing 5% dextrose+0.9% NaCl and 40 mEq/L KCl. Ondansetron (8 mg IV) was administered for severe nausea and vomiting. Since the ingested formulation was extended-release, multiple-dose activated charcoal (50 g every 6 hours) and polyethylene glycol were administered to enhance elimination (5, 6). Within the first hour of admission, continuous venovenous hemodiafiltration was initiated due to ventricular ectopy and tachycardia reaching 220 bpm. A 12 Fr femoral dialysis catheter was inserted; dialysate flow was 2000 mL/1.73 m2/hr and replacement was 35 mL/kg/hr, using standard solutions containing 2 mmol/L K+, without net ultrafiltration.

Additionally, TPE with 4% albumin was performed once. Electroencephalography showed periodic epileptiform discharges, and midazolam infusion was started. After 32 hours of hemodialysis, blood pressure stabilized, sinus rhythm was restored, and dialysis was terminated. Following 92 hours of intensive care monitoring, the patient was discharged for psychiatric and social services follow-up.

All types of arrhythmias can develop during theophylline intoxication, ranging from sinus tachycardia to ventricular fibrillation. Extracorporeal treatment methods such as hemodialysis and hemoperfusion are preferred in severe ventricular arrhythmias, while calcium channel blockers or β-blockers may be used in supraventricular tachycardia (7). In our patient, sinus tachycardia and ventricular extrasystoles improved following the combined use of hemodialysis and TPE.

We consider that the uninterrupted combined use of hemodialysis and TPE contributed to the rapid improvement in hemodynamic findings. Although the literature suggests that TPE is less effective than hemodialysis or hemoperfusion for theophylline elimination, our experience indicates that TPE may still be beneficial in selected cases (8).

In conclusion, close monitoring is essential because acute theophylline intoxication can be fatal, particularly from cardiac and neurological complications. The combined use of hemodialysis and TPE may provide rapid resolution of symptoms and should be considered in severe cases that are unresponsive to supportive therapy.

Keywords:

Authorship Contributions

Surgical and Medical Practices: N.A., E.Ş., Concept: N.A., Design: M.E.M., E.Ş., Data Collection or Processing: M.E.M., N.A., Analysis or Interpretation: E.Ş., Literature Search: M.E.M., N.A., E.Ş., Writing: M.E.M.
Conflict of Interest: No conflict of interest was declared by the authors.
Financial Disclosure: The authors declare that this study received no financial support.

References

1
Marshall H, Emerman CL, Tintinalli J. Theophylline: toxicology and pharmacology. In: Tintinalli JE, editor. Emergency Medicine: A Comprehensive Study Guide. 6th ed. New York: McGraw-Hill; 2004. p. 1098-101.
2
Satar S, Balal M, Gülalp B. Extracorporeal treatment methods and theophylline intoxication. In: Clinical toxicology in the emergency. 1st ed. Adana: Nobel Medicine Bookstore; 2009. p. 101-11, 271-6.
3
Çevik Y, Kavalcı C, Daş M, İzdeş S. Severe theophylline intoxication, rhabdomyolysis, disseminated intravascular coagulopathy and death: case report. AKA-TOS. 2010;1:24-7.
4
Sal E, Kaya A, Temel H, Başaranoğlu M, Çaksen H. A case with theophylline intoxication. Türk Pediatri Arş. 2013;48:55-6.
5
Ghannoum M, Wiegand TJ, Liu KD, Calello DP, Godin M, Lavergne V, et al.; EXTRIP workgroup. Extracorporeal treatment for theophylline poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila). 2015;53:215-29.
6
Laussen P, Shann F, Butt W, Tibballs J. Use of plasmapheresis in acute theophylline toxicity. Crit Care Med. 1991;19:288-90.
7
Hoffman RS, Nelson LS, Howland MA, Lewin NA, Flomenbaum NE, Goldfrank LR. Methylxanthines and selective β2-adrenergic agonists. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Howland MA, Nelson LS, Hoffman RS, editors. Goldfrank’s Manual of Toxicologic Emergencies. New York: McGraw-Hill; 2007. p. 553-9.
8
Nenov VD, Marinov P, Sabeva J, Nenov DS. Current applications of plasmapheresis in clinical toxicology. Nephrol Dial Transplant. 2003;18(Suppl 5):v56-8.